The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the results of ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbableย stents, and renal stents.ย
January 10, 2017 โย Medinol announced in December positive twelve-month clinical results from the BIONICS study.ย The ...
January 2, 2017 โ The U.S. Food and Drug Administration (FDA) hopes to build clinical evidence through new registries ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
The Diagnostic and Interventional Cardiology (DAIC) website had a record year in 2016, breaking 1 million page views for ...
December 13, 2016 โ Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18 bare metal ...
December 8, 2016 โ LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow ...
November 18, 2016 โ InspireMD Inc. announced in mid-October the online publication of positive clinical data in a new ...
November 10, 2016 โ Current ACCF/AHA guidelines recommend fibrinolysis (FL) as the preferred reperfusion strategy for ST ...
November 9, 2016 โ A dedicated stent study conducted exclusively in women and minority patients evaluated clinical ...
November 9, 2016 โ Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute ...
November 7, 2016 โ Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...
November 7, 2016 โ The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high ...
November 7, 2016 โ The 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 3 ...